DoW Rare Cancers Concept Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 17, 2026
- Amount
- Program total $2.5M
- Closes
- Sep 30, 2026 (in 13 days)
Similar opportunities open now
- DoW Rare Cancers Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 62 days
- DoW Rare Cancers Resource and Community Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 62 days
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 11 days
- DoW Bone Marrow Failure, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 48 days
- DoW Peer Reviewed Cancer, Idea AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 18 days
Classification and identifiers
- Solicitation number
- HT942526RCRPCA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $2.5M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. Applications must describe how the new idea will be innovative and present as a novel course of investigation in the field of rare cancers. Distinctive Features: Preliminary data are not required. Due to the blinded nature of the review process, identifying or making references to the Principal Investigator (PI), collaborator(s), or their organization(s) in the proposal Project Narrative, Supporting Documentations, Impact Statement, Justification Statement, and Statement of Work (SOW) is prohibited and will result in administrative rejection of the application.